Core Viewpoint - The company New Hope (新诺威) has signed a share transfer agreement with CSPC Pharmaceutical Group Limited (石药控股) to sell 30.0704% of its shares in Beijing Guoxin Huijin Co., Ltd. for 230 million yuan, aiming to optimize its asset structure and improve operational efficiency [1] Group 1 - The share transfer is based on a comprehensive consideration of the company's development situation, which will help optimize resource allocation and focus on core business [1] - The transaction is expected to enhance the company's financial structure, reduce operational risks, and promote high-quality development [1] - Proceeds from the share transfer will be used to supplement the company's daily operational funds, supporting business development in line with the company's long-term strategic planning [1]

Core Viewpoint - Ningbo Fuda (600724.SH) aims to optimize its equity structure and reduce operational risks by selling 100% equity of its wholly-owned subsidiary, Hekou Yingzhou Cement Co., Ltd. [1] Group 1 - The sale will be conducted through public listing at Ningbo Property Rights Exchange [1] - The assessed value of Hekou Company's total equity is 1.5752 million yuan [1] - Following the transaction, the subsidiary Mengzi Company will no longer hold any equity in Hekou Company, and Hekou Company will be excluded from the consolidated financial statements of the company [1]